基本信息
浏览量:14
职业迁徙
个人简介
Dr. Larrick’s main focus is protein therapeutics, but his research breadth covers a diverse range of scientific disciplines to create novel therapeutic candidates. His is a leading expert in the research of: sepsis, innate and adaptive immunity, antibody therapeutics, antibody humanization, biology of human aging,
Dr. James Larrick is a biomedical entrepreneur with an international reputation in biotechnology [cytokines, therapeutic antibodies, molecular biology, pharmaceutical drug development] having written or co-authored eight books, over 250 papers/chapters and >forty patents in his twenty-five year career. He has served on the editorial board of six journals.
研究兴趣
论文共 421 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Berkeley Pharma Tech Journal of Medicineno. 1 (2023): 1-9
Bo Yu,Aleksandra Drelich,Jason Hsu,Vivian Tat,Bi-Hung Peng, Qisheng Wei, Jianming Wang, Hong Wang,John Wages,Andrew R. Mendelsohn,James W. Larrick,Chien-Te Tseng
Boris Hespeels,Diego Fontaneto,Valérie Cornet,Sébastien Penninckx,Jérémy Berthe,Lucie Bruneau,James W. Larrick, Eloïse Rapport, Jérémie Bailly,Nicolas Debortoli,Nataliia Iakovenko,Karel Janko,
Scott M Wemlinger,Chelsea R Parker Harp,Bo Yu,Ian R Hardy, Matthew Seefeldt,Jennifer Matsuda,Michael Mingueneau, Kerri A Spilker,Thomas O Cameron,James W Larrick,Andrew Getahun,John C Cambier
Journal of immunology (Baltimore, Md. : 1950)no. 7 (2022): 1566-1584
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn